Injured Endothelial Cell: A Risk Factor for Pulmonary Fibrosis

被引:19
|
作者
Zhao, Weiming [1 ]
Wang, Lan [1 ]
Wang, Yaxuan [1 ]
Yuan, Hongmei [1 ]
Zhao, Mengxia [1 ]
Lian, Hui [1 ]
Ma, Shuaichen [1 ]
Xu, Kai [1 ]
Li, Zhongzheng [1 ]
Yu, Guoying [1 ]
机构
[1] Henan Normal Univ, Inst Biomed Sci, Henan Ctr Outstanding Overseas Scientists Organ Fi, Coll Life Sci,State Key Lab Cell Differentiat & Re, Xinxiang 453007, Peoples R China
关键词
pulmonary fibrosis; endothelial cells; endothelial-mesenchymal transition; myofibroblasts; TO-MESENCHYMAL TRANSITION; NF-KAPPA-B; GROWTH-FACTOR; TRANSCRIPTION FACTOR; CONTROLLED-TRIAL; STRESS; EXPRESSION; PERICYTES; TRANSFORMATION; MACROPHAGES;
D O I
10.3390/ijms24108749
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pathological features of pulmonary fibrosis (PF) are the abnormal activation and proliferation of myofibroblasts and the extraordinary deposition of the extracellular matrix (ECM). However, the pathogenesis of PF is still indistinct. In recent years, many researchers have realized that endothelial cells had a crucial role in the development of PF. Studies have demonstrated that about 16% of the fibroblasts in the lung tissue of fibrotic mice were derived from endothelial cells. Endothelial cells transdifferentiated into mesenchymal cells via the endothelial-mesenchymal transition (E(nd)MT), leading to the excessive proliferation of endothelial-derived mesenchymal cells and the accumulation of fibroblasts and ECM. This suggested that endothelial cells, a significant component of the vascular barrier, played an essential role in PF. Herein, this review discusses E(nd)MT and its contribution to the activation of other cells in PF, which could provide new ideas for further understanding the source and activation mechanism of fibroblasts and the pathogenesis of PF.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis
    Garcia-Sancho, Cecilia
    Buendia-Roldan, Ivette
    Rosario Fernandez-Plata, Ma
    Navarro, Carmen
    Perez-Padilla, Rogelio
    Vargas, Mario H.
    Loyd, James E.
    Selman, Moises
    RESPIRATORY MEDICINE, 2011, 105 (12) : 1902 - 1907
  • [2] Pulmonary fibrosis as a risk factor for thromboembolic disease
    Shereen Farghaly
    Ashraf Z. El-Abdin
    Egyptian Journal of Bronchology, 2015, 9 (2) : 160 - 164
  • [3] Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis
    Murray, Lynne A.
    Habiel, David M.
    Hohmann, Miriam
    Camelo, Ana
    Shang, Huilan
    Zhou, Yang
    Coelho, Ana Lucia
    Peng, Xueyan
    Gulati, Mridu
    Crestani, Bruno
    Sleeman, Matthew A.
    Mustelin, Tomas
    Moore, Meagan W.
    Ryu, Changwan
    Osafo-Addo, Awo D.
    Elias, Jack A.
    Lee, Chun G.
    Hu, Buqu
    Herazo-Maya, Jose D.
    Knight, Darryl A.
    Hogaboam, Cory M.
    Herzog, Erica L.
    JCI INSIGHT, 2017, 2 (16):
  • [4] PULMONARY ENDOTHELIAL CELL SECRETION OF FACTOR VIII
    Shovlin, C. L.
    Manning, R.
    Angus, G.
    Laffan, M.
    Birdsey, G.
    Mauri, F. A.
    THORAX, 2008, 63 : A42 - A42
  • [5] IDIOPATHIC PULMONARY FIBROSIS IS A POSSIBLE RISK FACTOR FOR OSTEOPOROSIS
    Nikaido, Takefumi
    Tanino, Yoshinori
    Sato, Yuki
    Togawa, Ryuichi
    Suzuki, Yasuhito
    Uematsu, Manabu
    Fukuhara, Atsuro
    Sato, Suguru
    Saito, Junpei
    Shibata, Yoko
    RESPIROLOGY, 2018, 23 : 276 - 276
  • [6] Short telomeres are a risk factor for idiopathic pulmonary fibrosis
    Alder, Jonathan K.
    Chen, Julian J. -L.
    Lancaster, Lisa
    Danoff, Sonye
    Su, Shu-Chih
    Cogan, Joy D.
    Vulto, Irma
    Xie, Mingyi
    Qi, Xiaodong
    Tuder, Rubin M.
    Phillips, John A., III
    Lansdorp, Peter M.
    Loyd, James E.
    Armanios, Mary Y.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) : 13051 - 13056
  • [7] Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis
    Baumgartner, KB
    Samet, JM
    Stidley, CA
    Colby, TV
    Waldron, JA
    Coultas, DB
    Davis, GS
    Garcia, JGN
    Hunninghake, GW
    Kallay, MC
    King, TE
    Krowka, MJ
    Rennard, SI
    Ryu, JH
    Sherman, CB
    Smith, LJ
    Toews, G
    Winterbauer, RH
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (01) : 242 - 248
  • [8] Vascular Endothelial Growth Factor in Idiopathic Pulmonary Fibrosis An Imbalancing Act
    Atamas, Sergei P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (04) : 409 - 411
  • [9] Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
    Barratt, Shaney
    Jarrett, Caroline
    Welsh, Gavin
    Bates, David
    Millar, Ann
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [10] Regulating the cell shift of endothelial cell-like myofibroblasts in pulmonary fibrosis
    Wu, Xiuju
    Zhang, Daoqin
    Qiao, Xiaojing
    Zhang, Li
    Cai, Xinjiang
    Ji, Jaden
    Ma, Jocelyn A.
    Zhao, Yan
    Belperio, John A.
    Bostrom, Kristina I.
    Yao, Yucheng
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (06)